logo

For the Inventor, By the Inventor

Rixensart, Belgium

Glaxosmithkline Biologicals Sa


USPTO Granted Patents = 531



Trademarks = 141

Forward Citations = 2,279

Loading Chart...
Loading Chart...

911 inventors (with patents filed for the assignee):

goldMedal Andrew John Geall (53 out of 99 patents)

silverMedal Jan Poolman (45 out of 47 patents)

bronzeMedal Mariagrazia Pizza (35 out of 82 patents)

4.  Ralph Leon Biemans (33 out of 33 patents)

5.  Michael T Kowarik (28 out of 35 patents)

6.  Maria Scarselli (27 out of 59 patents)

7.  Guido Grandi (24 out of 110 patents)

8.  Francesco Berti (23 out of 30 patents)

9.  Paolo Costantino (23 out of 34 patents)

10.  Gillis Otten (22 out of 24 patents)

11.  Manmohan Singh (22 out of 54 patents)

12.  Derek T O'Hagan (22 out of 73 patents)

13.  Katrin Ramsauer (20 out of 22 patents)

14.  Christian Walter Mandl (20 out of 20 patents)

15.  Normand Blais (20 out of 21 patents)


Core Competencies:
Nucleic Acid Manipulation
Cytomegalovirus Proteins
Meningococcal Polypeptides
Bioconjugates Production
RNA Vaccines
Immunogenic Compositions
Saponin Purification
Epstein-Barr Virus Constructs
Adjuvant Manufacturing
Polysaccharide Applications
Immune Response Induction
Lipid Formulations

531 patents:

1. 12442019 - Process for the manipulation of nucleic acids (2025-10-14),
2. 12419949 - Modified human cytomegalovirus proteins (2025-09-23),
3. 12415838 - Modified meningococcal fHbp polypeptides (2025-09-16),
4. 12409231 - Cycloalkyne derivatized saccharides (2025-09-09),
5. 12398380 - Methods of host cell modification (2025-08-26),
6. 12384819 - Modified cytomegalovirus proteins and stabilized complexes (2025-08-12),
7. 12312384 - Modified meningococcal fHbp polypeptides (2025-05-27),
8. 12264179 - Epstein-Barr Virus antigen constructs (2025-04-01),
9. 12233121 - Methods of producing bioconjugates ofO-antigen polysaccharides, compositions thereof, and methods of use thereof (2025-02-25),
10. 12227540 - Saponin purification (2025-02-18),
11. 12215378 - RNA identity method using RNAse H digestion and size fractionating (2025-02-04),
12. 12214029 - Polysaccharide and uses thereof (2025-02-04),
13. 12186389 - Nucleic acid base vaccine against emerging SARS-CoV-2 variants (2025-01-07),
14. 12186333 - Delivery of RNA to trigger multiple immune pathways (2025-01-07),
15. 12180512 - Simian adenoviral vectors with two expression cassettes (2024-12-31),
GSK is a leading global healthcare company that focuses on developing innovative products and solutions to improve human health. GSK Biologicals SA, a division of GSK, specializes in the research, development, and manufacturing of biological vaccines. With a commitment to scientific excellence, GSK Biologicals SA strives to protect individuals and communities worldwide against infectious diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
531 Patents

#1 in Rixensart

#6 in Belgium

#1,779 in the World

...
Rixensart, Belgium

Glaxosmithkline Biologicals Sa

Forward Citations = 2,279

911 inventors:

goldMedal Andrew John Geall (53 out of 99 patents)

silverMedal Jan Poolman (45 out of 47 patents)

bronzeMedal Mariagrazia Pizza (35 out of 82 patents)

4.  Ralph Leon Biemans (33 out of 33 patents)

5.  Michael T Kowarik (28 out of 35 patents)

Please report any incorrect information to support@idiyas.com
Loading…